Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Lexeo Therapeuticslexeotx.com · Low evidenceLexeo Therapeutics focuses on developing genetic medicine candidates for cardiovascular diseases and APOE4-associated Alzheimer’s disease. The company builds on research from Weill Cornell Medicine and UC San Diego, partnering with leading institutions to advance gene therapy.
Parse Score